RXMAPPER Trademark

Trademark Overview


On Tuesday, May 17, 2022, a trademark application was filed for RXMAPPER with the United States Patent and Trademark Office. The USPTO has given the RXMAPPER trademark a serial number of 97981292. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Thursday, March 5, 2026. This trademark is owned by RxMapper, LLC. The RXMAPPER trademark is filed in the Advertising, Business and Retail Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Telemedicine services; Clinical medical consultation services; Medical and pharmaceutical consultation, advice, and medical analysis services for the diagnosis of conditions and diseases for genomic maladies; Pharmaceutical drug advice; Pharmaceutical drug utilization advice; Health assessment services, namely, providing pharmaceutical drug and, drug utilization for diagnosis and treatment of conditions and diseases for genomic maladies; Genomic benefit management services, namely, medical diagnosis, namely, translations of complex genomic sequencing for use in individualized patient treatment plans by non-genomic health care physicians and health care professionals for the diagnosis and treatment of diseases and conditions; managed medical care and pharmaceutical consultation; Providing an Internet website portal featuring medical information in the fields of medicine and pharmaceuticals

Pharmaceutical cost management services and drug utilization review services; Business consulting, business management, and business cost analysis of medical diagnosis, medical treatment, pharmaceutical cost management and drug utilization
rxmapper

General Information


Serial Number97981292
Word MarkRXMAPPER
Filing DateTuesday, May 17, 2022
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateThursday, March 5, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 11, 2023

Trademark Statements


Goods and ServicesTelemedicine services; Clinical medical consultation services; Medical and pharmaceutical consultation, advice, and medical analysis services for the diagnosis of conditions and diseases for genomic maladies; Pharmaceutical drug advice; Pharmaceutical drug utilization advice; Health assessment services, namely, providing pharmaceutical drug and, drug utilization for diagnosis and treatment of conditions and diseases for genomic maladies; Genomic benefit management services, namely, medical diagnosis, namely, translations of complex genomic sequencing for use in individualized patient treatment plans by non-genomic health care physicians and health care professionals for the diagnosis and treatment of diseases and conditions; managed medical care and pharmaceutical consultation; Providing an Internet website portal featuring medical information in the fields of medicine and pharmaceuticals
Goods and ServicesPharmaceutical cost management services and drug utilization review services; Business consulting, business management, and business cost analysis of medical diagnosis, medical treatment, pharmaceutical cost management and drug utilization

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, May 23, 2022
Primary Code035
First Use Anywhere DateWednesday, January 8, 2025
First Use In Commerce DateWednesday, January 8, 2025

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 23, 2022
Primary Code044
First Use Anywhere DateMonday, July 1, 2024
First Use In Commerce DateMonday, July 1, 2024

Trademark Owner History


Party NameRxMapper, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressScottsdale, AZ 85260
US

Party NameRxMapper, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWellesley, MA 02481
US

Trademark Events


Event DateEvent Description
Friday, May 20, 2022NEW APPLICATION ENTERED
Monday, May 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 6, 2023ASSIGNED TO EXAMINER
Tuesday, March 7, 2023NON-FINAL ACTION WRITTEN
Tuesday, March 7, 2023NON-FINAL ACTION E-MAILED
Tuesday, March 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 21, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 11, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 5, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 5, 2024SOU EXTENSION 1 FILED
Tuesday, March 5, 2024SOU EXTENSION 1 GRANTED
Wednesday, March 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 5, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 5, 2024SOU EXTENSION 2 FILED
Thursday, September 5, 2024SOU EXTENSION 2 GRANTED
Thursday, September 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 5, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, March 5, 2025SOU EXTENSION 3 FILED
Thursday, March 6, 2025SOU EXTENSION 3 GRANTED
Thursday, March 6, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 5, 2025TEAS REQUEST TO DIVIDE RECEIVED
Friday, September 5, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, January 14, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, January 18, 2026ASSIGNED TO EXAMINER
Wednesday, February 18, 2026ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Monday, February 23, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 23, 2026RESPONSE TO ITU OFFICE ACTION ENTERED
Friday, September 5, 2025DIVISIONAL REQUEST RECEIVED
Thursday, March 5, 2026DIVISIONAL PROCESSING COMPLETE
Friday, September 5, 2025USE AMENDMENT FILED
Thursday, March 5, 2026STATEMENT OF USE PROCESSING COMPLETE